Patent: 10,468,123
✉ Email this page to a colleague
Summary for Patent: 10,468,123
| Title: | Self correction for spatial orientation and motion of portable clinical analyzers |
| Abstract: | The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth\'s gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof. |
| Inventor(s): | Vandersleen; Gary (Plainsboro, NJ), Emeric; Pierre (Princeton, NJ), Wasserman; Paul (Oakhurst, NJ), Soman; Narendra (Hillsborough, NJ), Davis; Graham (Princeton, NJ) |
| Assignee: | Abbott Point of Care Inc. (Princeton, NJ) |
| Application Number: | 15/877,626 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,468,123
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | January 15, 1974 | 10,468,123 | 2038-01-23 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | December 27, 1984 | 10,468,123 | 2038-01-23 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 15, 1985 | 10,468,123 | 2038-01-23 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 16, 1990 | 10,468,123 | 2038-01-23 |
| Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | March 26, 1974 | 10,468,123 | 2038-01-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
